ATE344054T1 - Behandlung von okularen neovaskularen erkrankungen - Google Patents

Behandlung von okularen neovaskularen erkrankungen

Info

Publication number
ATE344054T1
ATE344054T1 AT02787238T AT02787238T ATE344054T1 AT E344054 T1 ATE344054 T1 AT E344054T1 AT 02787238 T AT02787238 T AT 02787238T AT 02787238 T AT02787238 T AT 02787238T AT E344054 T1 ATE344054 T1 AT E344054T1
Authority
AT
Austria
Prior art keywords
treatment
occular
neovascular diseases
diseases
neovascular
Prior art date
Application number
AT02787238T
Other languages
English (en)
Inventor
Philippe Maria Clotai Margaron
Jing-Song Tao
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE344054T1 publication Critical patent/ATE344054T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
AT02787238T 2001-11-30 2002-11-29 Behandlung von okularen neovaskularen erkrankungen ATE344054T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33528701P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
ATE344054T1 true ATE344054T1 (de) 2006-11-15

Family

ID=23311112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02787238T ATE344054T1 (de) 2001-11-30 2002-11-29 Behandlung von okularen neovaskularen erkrankungen

Country Status (10)

Country Link
US (1) US20050074455A1 (de)
EP (1) EP1467761B1 (de)
AT (1) ATE344054T1 (de)
AU (1) AU2002351908A1 (de)
CA (1) CA2466864A1 (de)
DE (1) DE60215864T2 (de)
DK (1) DK1467761T3 (de)
ES (1) ES2275933T3 (de)
PT (1) PT1467761E (de)
WO (1) WO2003045432A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1417976A4 (de) * 2001-07-26 2004-09-15 Santen Pharmaceutical Co Ltd Mittel zur behandlung von glaukom mit einer verbindung mit pi3-kinase-hemmender wirkung als wirkstoff
US7479277B2 (en) * 2005-02-24 2009-01-20 Wisconsin Alumni Research Foundation Method for reducing intraocular pressure using integrin-linked kinase inhibitor
US8740383B2 (en) 2009-05-06 2014-06-03 University Of Virginia Patent Foundation Self-illuminated handheld lens for retinal examination and photography and related method thereof
IT201800005693A1 (it) * 2018-05-24 2019-11-24 Apparecchiatura per trattamenti biofotonici tissutali

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001622A (en) * 1995-12-21 1999-12-14 Sunnybrook Health Science Centre Integrin-linked kinase and its use
US6833436B2 (en) * 1997-05-21 2004-12-21 Children's Medical Center Corporation Short peptides which selectively modulate the activity of serine/threonine kinases
CA2245029A1 (en) * 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
WO2004073708A1 (en) * 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
US6177273B1 (en) * 1999-10-26 2001-01-23 Isis Pharmaceuticals Inc. Antisense modulation of integrin-linked kinase expression
US6436915B1 (en) * 2000-04-07 2002-08-20 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US6420400B1 (en) * 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6214813B1 (en) * 2000-04-07 2001-04-10 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6403588B1 (en) * 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
ATE300540T1 (de) * 2000-04-27 2005-08-15 Yamanouchi Pharma Co Ltd Imidazopyridin-derivate

Also Published As

Publication number Publication date
EP1467761B1 (de) 2006-11-02
WO2003045432A8 (en) 2003-08-14
AU2002351908A8 (en) 2003-06-10
DE60215864D1 (de) 2006-12-14
EP1467761A1 (de) 2004-10-20
AU2002351908A1 (en) 2003-06-10
PT1467761E (pt) 2007-02-28
ES2275933T3 (es) 2007-06-16
CA2466864A1 (en) 2003-06-05
DE60215864T2 (de) 2007-05-31
WO2003045432A1 (en) 2003-06-05
DK1467761T3 (da) 2007-02-05
US20050074455A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
EA200400518A1 (ru) Способы лечения глазных неоваскулярных заболеваний
DE60101265D1 (de) Behandlung von augenschmerzen
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
EA201000441A1 (ru) Водные офтальмологические препараты
DK1239774T3 (da) Apparat til behandling af öjensygdomme
WO2004004757A8 (en) Treatment for eye disorder
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
CY1108983T1 (el) Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων
NO20015969L (no) Forbedret skleral protese for behandling av presbyopi og andre öyesykdommer
EA200300560A1 (ru) Улучшенный способ лечения
DE502004010981D1 (de) Intraokulare linseneinrichtung zur verbesserung des sehvermögens bei netzhauterkrankungen
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
BRPI0517972A (pt) ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
ATE344054T1 (de) Behandlung von okularen neovaskularen erkrankungen
ATE252387T1 (de) Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
BRPI0411427A (pt) formulações de agentes antiinflamatórios não-esteróides para o tratamento de angiogênese ocular patológica
WO2002015942A8 (en) Method for the identification of agents that inhibit or promote cataracts and uses thereof
PT1169026E (pt) Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular
CY1114337T1 (el) Γονιδιακη μεταφορα με την μεσολαβηση φορεα λεντοϊων και χρησεις αυτης
WO2004073499A3 (en) Diagnosis of primary open angle glaucoma
BR9901566A (pt) Análogos cis-delta4 de prostaglandinas como hipotensores oculares

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1467761

Country of ref document: EP

REN Ceased due to non-payment of the annual fee